Cencora

COR · Health Care · Market cap $60.8B

Q4 FY25 Jul 1 – Sep 30, 2025 reported Nov 25, 2025

Revenue$83.7B +6% year over year

Gross profit$3B

Operating profit$0B

Net profit$-0.3B 0% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	83.7	100%	+6%
US Healthcare Solutions	75.8	91%	+6%
International Healthcare	7.9	9%	+8%
Cost of revenue	−80.8	97%
Gross profit	3	4% margin	+0pp
SG&A	−1.7	2%	+0pp
Other	−1.2	1%	+0pp
Operating profit	0	0% margin	+0pp
Tax	−0.1
Interest & other costs	−0.2
Net profit	-0.3	0%	+0pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	80.7	100%	+9%
US Healthcare Solutions	72.9	90%	+8%
International Healthcare	7.8	10%	+10%
Cost of revenue	−77.8	96%
Gross profit	2.9	4% margin	+0pp
SG&A	−1.6	2%	+0pp
Other	−0.4	0%	+0pp
Operating profit	0.9	1% margin	+0pp
Tax	−0.2
Net profit	0.7	1%	+0pp

All figures in billions of U.S. dollars, for Q4 FY24 (period ends Sep 30, 2024).
Item	Value	Share of revenue	Year over year
Revenue	79.1	100%	+15%
US Healthcare Solutions	71.7	91%	+16%
International Healthcare	7.4	9%	+6%
Cost of revenue	−76.6	97%
Gross profit	2.5	3% margin	+0pp
SG&A	−1.5	2%	+0pp
Other	−0.9	1%	+0pp
Operating profit	0.1	0% margin	−1pp
Tax	−0.1
Net profit	0	0%	−1pp

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Jun 30, 2024).
Item	Value	Share of revenue	Year over year
Revenue	74.2	100%	+11%
US Healthcare Solutions	67.2	91%	+12%
International Healthcare	7.1	10%	+0%
Cost of revenue	−71.8	97%
Gross profit	2.4	3% margin	+0pp
SG&A	−1.4	2%	+0pp
Other	−0.4	0%	+0pp
Operating profit	0.7	1% margin	+0pp
Tax	−0.2
Net profit	0.5	1%	+0pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q4 FY25	Jul 1 – Sep 30, 2025	Nov 25, 2025	$83.7B	+6%	0%	$-0.3B	0%
Q3 FY25	Jun 30, 2025	Aug 6, 2025	$80.7B	+9%	1%	$0.7B	1%
Q4 FY24	Jul 1 – Sep 30, 2024	Nov 26, 2024	$79.1B	+15%	0%	$0B	0%
Q3 FY24	Apr 1 – Jun 30, 2024	Jul 31, 2024	$74.2B	+11%	1%	$0.5B	1%